PANACEABIO logo

Panacea Biotec LTD

PANACEABIO·NSE·
391.80 +4.70 (+1.21%)
Market Cap2408.01 Cr
PE Ratio-269.30
Volume1,02,491
Day High - Low397.25 - 384.00
52W High-Low647.00 - 292.40
DocStoX Score
0.0/10
Poor
Fair Value
Sign in to see
ROE
-2.36%
Weak
P/E
-269.30x
Loss-making
Debt / Equity
0.93
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day384.00
397.25
52W292.40
647.00
DocStoX take

Held back by valuation (0.0).

DocStoX score

Low confidence
0.0
/10
Poor
Quality
Weak
ROE -2.4%
Valuation
Expensive
P/B 11.9× on assets (no earnings to value)
Growth
Flat
Revenue +0.5% 5Y CAGR
Risk
Moderate
D/E 0.93
Momentum
Weak
28% of 52-week range

At a glance

Market Cap
₹2,408 Cr
52W High / Low
₹647 / ₹292
Dividend Yield
0.00%
Promoter Holding
72.48%
EPS (TTM)
₹-0.88
Book Value
₹136.00

Key highlights

  • Loss-making — no meaningful P/E
  • Loss-making in some of the last 5 years
0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

PANACEA BIOTEC LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.